Tag: 483 FDA warning

October 19, 2026

The AI Act, Regulation (EU) 2024/1689, was adopted on 13 June 2024 and applies generally from 2 August 2026. Regulation

October 19, 2026

The investigational device exemption (IDE) is the framework that allows an unapproved device to be used in a clinical investigation

October 19, 2026

A Form FDA 483 and an FDA Warning Letter are not the same document. A 483 lists the investigator's observations

October 16, 2026

For medical devices, an FDA adverse event report is a Medical Device Report (MDR) under 21 CFR Part 803. The

October 15, 2026

A De Novo review is FDA's risk-based classification route for a novel device that has no legally marketed predicate, but

October 13, 2026

Device listing is the part of FDA registration that most teams touch once a year and otherwise forget. That is

October 9, 2026

ISO 27001 Requirements: A Clause-by-Clause Reference ISO/IEC 27001 has been the reference standard for information security management systems since 2005,

October 5, 2026

21 CFR Part 11 began as a permission, not a mandate. The FDA published it in March 1997, in 62

October 3, 2026

The shift from Directive 98/79/EC to Regulation (EU) 2017/746, the In Vitro Diagnostic Regulation, changed the route to IVD CE

Stay Informed

Follow us on LinkedIn for the latest medical device regulatory affairs and industry news.

logo

Unlock Your Quick Guide to AI Act
Compliance!

Explore AI-enabled SaMD requirements with our easy step-by-step guide.

Cookies help us improve your experience on our website. By using our site, you consent to the use of cookies as described in this policy.